Kymera Therapeutics, Inc.
KYMR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$82 | -$77 | -$66 | -$71 |
| Dep. & Amort. | $2 | $2 | $2 | $2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $16 | $15 | $14 | $14 |
| Change in WC | $38 | $1 | -$27 | $3 |
| Other Non-Cash | -$1 | -$2 | -$3 | -$10 |
| Operating Cash Flow | -$27 | -$60 | -$79 | -$62 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$58 | -$84 | $0 |
| Inv. Sales/Matur. | $0 | $117 | $130 | $0 |
| Other Inv. Act. | -$235 | $2 | $3 | $70 |
| Investing Cash Flow | -$235 | $60 | $49 | $69 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$0 | -$0 | -$0 |
| Stock Issued | $0 | $246 | $1 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $40 | $0 | $0 | $3 |
| Financing Cash Flow | $40 | $246 | $0 | $3 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$223 | $246 | -$30 | $10 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $342 | $96 | $126 | $117 |
| End Cash | $119 | $342 | $96 | $126 |
| Free Cash Flow | -$27 | -$61 | -$80 | -$63 |